Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Comets

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Pharmaceutical Statistics|March 5, 2013
A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects modelsHoai-Thu Thai, France Mentré, Nicholas H G Holford, et al.
Computer Methods and Programs in Biomedicine|February 12, 2018
PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect modelsCyrielle Dumont, Giulia Lestini, Hervé Le Nagard, et al.
The AAPS Journal|May 24, 2024
Correction: Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS)Niels Hendrickx, France Mentré, Andreas Traschütz, et al.
The AAPS Journal|April 30, 2024
Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS)Niels Hendrickx, France Mentré, Andreas Traschütz, et al.
British Journal of Clinical Pharmacology|August 4, 2017
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic childrenChristelle Rodrigues, Catherine Chiron, Elisabeth Rey, et al.
Biometrical Journal. Biometrische Zeitschrift|March 22, 2017
Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populationsMoreno Ursino, Sarah Zohar, Frederike Lentz, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2010
Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosaNicolas Grégoire, Sophie Raherison, Claire Grignon, et al.
Scientific Reports|October 12, 2017
A minimal resting time of 25 min is needed before measuring stabilized blood pressure in subjects addressed for vascular investigationsGuillaume Mahe, Emmanuelle Comets, Aziz Nouni, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Designing a Pediatric Study for an Antimalarial Drug by Using Information from AdultsCaroline Petit, Vincent Jullien, Adeline Samson, et al.
Statistical Methods in Medical Research|March 6, 2024
Bayesian framework for multi-source data integration-Application to human extrapolation from preclinical studiesSandrine Boulet, Moreno Ursino, Robin Michelet, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Pharmaceutical Statistics|March 5, 2013
A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects modelsHoai-Thu Thai, France Mentré, Nicholas H G Holford, et al.
Computer Methods and Programs in Biomedicine|February 12, 2018
PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect modelsCyrielle Dumont, Giulia Lestini, Hervé Le Nagard, et al.
The AAPS Journal|May 24, 2024
Correction: Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS)Niels Hendrickx, France Mentré, Andreas Traschütz, et al.
The AAPS Journal|April 30, 2024
Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS)Niels Hendrickx, France Mentré, Andreas Traschütz, et al.
British Journal of Clinical Pharmacology|August 4, 2017
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic childrenChristelle Rodrigues, Catherine Chiron, Elisabeth Rey, et al.
Biometrical Journal. Biometrische Zeitschrift|March 22, 2017
Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populationsMoreno Ursino, Sarah Zohar, Frederike Lentz, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2010
Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosaNicolas Grégoire, Sophie Raherison, Claire Grignon, et al.
Scientific Reports|October 12, 2017
A minimal resting time of 25 min is needed before measuring stabilized blood pressure in subjects addressed for vascular investigationsGuillaume Mahe, Emmanuelle Comets, Aziz Nouni, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Designing a Pediatric Study for an Antimalarial Drug by Using Information from AdultsCaroline Petit, Vincent Jullien, Adeline Samson, et al.
Statistical Methods in Medical Research|March 6, 2024
Bayesian framework for multi-source data integration-Application to human extrapolation from preclinical studiesSandrine Boulet, Moreno Ursino, Robin Michelet, et al.
Pageof 7